- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00546559
Differential Metabolic Effects of Statins
August 28, 2008 updated by: Gachon University Gil Medical Center
The investigators hypothesized simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Incheon, Korea, Republic of, 405760
- Gil Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Low-density lipoprotein cholesterol levels > 130
Exclusion Criteria:
- Overt liver disease,
- Chronic renal failure
- Hypothyroidism
- Myopathy
- Uncontrolled diabetes
- Severe hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kwang K Koh, MD,PhD, Gachon University Gil Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2004
Study Completion
March 1, 2008
Study Registration Dates
First Submitted
October 18, 2007
First Submitted That Met QC Criteria
October 18, 2007
First Posted (Estimate)
October 19, 2007
Study Record Updates
Last Update Posted (Estimate)
August 29, 2008
Last Update Submitted That Met QC Criteria
August 28, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Metabolic Diseases
- Lipid Metabolism Disorders
- Hyperlipidemias
- Dyslipidemias
- Hypercholesterolemia
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antimetabolites
- Anticholesteremic Agents
- Hypolipidemic Agents
- Lipid Regulating Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Pravastatin
- Simvastatin
Other Study ID Numbers
- GMC-200406
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineUnknownPrimary HypercholesterolemiaUnited States
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Boryung Pharmaceutical Co., LtdRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Ahn-Gook Pharmaceuticals Co.,LtdRecruitingPrimary HypercholesterolemiaKorea, Republic of
Clinical Trials on statins (simvastatin, pravastatin)
-
Rockefeller UniversityCornell University; Adelphi UniversityTerminated
-
Organon and CoMerck Sharp & Dohme LLCCompleted
-
Hospital Universitario 12 de OctubreMerck Sharp & Dohme LLCCompletedCardiovascular Diseases
-
Seattle Institute for Biomedical and Clinical ResearchCompleted
-
University of Kansas Medical CenterUniversity of Missouri-Columbia; American Heart AssociationCompleted
-
University of California, San DiegoNational Heart, Lung, and Blood Institute (NHLBI)CompletedDyslipidemiasUnited States
-
Mayo ClinicCompletedHypercholesterolemiaUnited States
-
Complexa, Inc.CompletedAcute Kidney InjuryUnited States
-
Pakistan Institute of Living and LearningKing's College LondonCompletedMajor Depressive Disorder | Treatment Resistant DepressionPakistan
-
Organon and CoCompleted